Research
Effects of semaglutide on cardiac structure and function in heart failure with preserved ejection fraction and obesity: a pre-specified cardiac magnetic resonance substudy of the CAMEO-SEMA trial
Nature ·
The Brief
- Reports a pre-specified cardiac magnetic resonance substudy of the CAMEO-SEMA trial.
- Examines semaglutide's effects on cardiac structure and function in heart failure with preserved ejection fraction and obesity.
Why it matters
It addresses how semaglutide may affect the heart in a common heart failure subtype linked to obesity. The available source gives only the title, so no specific findings can be reported.
Who’s affected
- People with heart failure with preserved ejection fraction and obesity
- Cardiology and heart failure researchers